With USFDA nod Abbott set to launch its point of care 5 mins coronavirus test-ID NOW COVID-19 Medical Dialogues Bureau28 March 2020 6:39 AM GMTAbbott will be making ID NOW COVID-19 tests available next week to healthcare providers in urgent care settings in the U.S., where the majority of ID...
Abbott gets USFDA emergency use authorization for COVID-19 molecular test Medical Dialogues Bureau20 March 2020 4:45 AM GMTThe Abbott m2000 RealTime System is a molecular solution featuring a broad menu of tests, including ones for infectious diseases.
Abbott introduces next-generation heart rhythm management devices in Europe Medical Dialogues Bureau19 Feb 2020 10:03 AM GMTAbbott Park: Abbott has announced it has received CE Mark for the new Gallant™ implantable cardioverter-defibrillator (ICD) and cardiac resynchronizati...
Abbott bags European nod for Tendyne Transcatheter Mitral Valve Implantation system Medical Dialogues Bureau1 Feb 2020 7:30 AM GMTNew Delhi: Abbott today announced that its Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use i...
Drug Alert: CDSCO declares 49 drug samples as Not of Standard Quality; Details Farhat Nasim14 Jan 2020 9:02 AM GMTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) recently flagged 49...
